Medidata Solutions Inc (NASDAQ:MDSO) CFO Rouven Bergmann sold 2,000 shares of the business’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $65.40, for a total transaction of $130,800.00. Following the transaction, the chief financial officer now directly owns 91,775 shares of the company’s stock, valued at approximately $6,002,085. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Shares of Medidata Solutions Inc (NASDAQ:MDSO) opened at $64.99 on Wednesday. Medidata Solutions Inc has a 52 week low of $47.77 and a 52 week high of $85.92. The company has a debt-to-equity ratio of 0.61, a quick ratio of 3.37 and a current ratio of 1.29. The firm has a market cap of $3,787.69, a PE ratio of 78.06, a price-to-earnings-growth ratio of 4.03 and a beta of 1.69.

Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings results on Thursday, October 26th. The company reported $0.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.31 by $0.02. Medidata Solutions had a net margin of 7.84% and a return on equity of 11.54%. The business had revenue of $140.08 million for the quarter, compared to analysts’ expectations of $141.27 million. During the same period in the prior year, the firm earned $0.28 earnings per share. Medidata Solutions’s revenue was up 16.7% compared to the same quarter last year. sell-side analysts predict that Medidata Solutions Inc will post 0.77 EPS for the current fiscal year.

A number of research analysts have recently commented on MDSO shares. Royal Bank Of Canada reaffirmed a “hold” rating and set a $80.00 price objective on shares of Medidata Solutions in a research report on Friday, October 27th. KeyCorp reaffirmed a “buy” rating and set a $86.00 price objective on shares of Medidata Solutions in a research report on Sunday, September 17th. Zacks Investment Research lowered shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research report on Thursday, November 2nd. Jefferies Group reaffirmed a “hold” rating and set a $78.00 price objective on shares of Medidata Solutions in a research report on Tuesday, August 22nd. Finally, Dougherty & Co raised shares of Medidata Solutions from a “neutral” rating to a “buy” rating and set a $75.00 price objective for the company in a research report on Monday, November 13th. Four analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $85.08.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Canada Pension Plan Investment Board boosted its stake in Medidata Solutions by 2,994.6% in the third quarter. Canada Pension Plan Investment Board now owns 1,151,200 shares of the company’s stock valued at $89,863,000 after acquiring an additional 1,114,000 shares during the last quarter. American Century Companies Inc. boosted its stake in Medidata Solutions by 610.9% in the third quarter. American Century Companies Inc. now owns 1,186,843 shares of the company’s stock valued at $92,645,000 after acquiring an additional 1,019,883 shares during the last quarter. Eagle Asset Management Inc. boosted its stake in Medidata Solutions by 292.9% in the third quarter. Eagle Asset Management Inc. now owns 835,286 shares of the company’s stock valued at $66,371,000 after acquiring an additional 622,694 shares during the last quarter. State Street Corp boosted its stake in Medidata Solutions by 27.7% in the second quarter. State Street Corp now owns 1,828,913 shares of the company’s stock valued at $143,022,000 after acquiring an additional 396,793 shares during the last quarter. Finally, Voya Investment Management LLC raised its holdings in Medidata Solutions by 1,571.0% in the second quarter. Voya Investment Management LLC now owns 376,259 shares of the company’s stock worth $29,423,000 after purchasing an additional 353,742 shares during the period. 97.52% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Rouven Bergmann Sells 2,000 Shares of Medidata Solutions Inc (MDSO) Stock” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/rouven-bergmann-sells-2000-shares-of-medidata-solutions-inc-mdso-stock/1746900.html.

About Medidata Solutions

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Insider Buying and Selling by Quarter for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.